PharmAsiaNews.com, a subscription-based online service of F-D-C Reports, Inc., US, has announced that Dr. Zhu Shen, chief executive officer of BioForesight, a leading global life science consulting firm, has joined the editorial advisory board of the service.
Dr. Shen's first guest column on Chinese CRO trends is entitled 'The Art of Selecting Outsourcing Partners in China: Navigating the Life Sciences Silk Road Frontier.' Subscribers to PharmAsiaNews.com may access the column at www.pharmasianews.com.
Dr. Shen is an organiser, speaker, and chair of numerous life science business conferences on licensing, venture investing, and cross-Pacific partnering/CRO trends. She serves on the Board of Directors and chairs the Pacific Alliance & Entrepreneurship Committee of Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA), the largest and most influential Chinese American life science professional organization in Southern California. She also serves on the BIOCOM Asia Task Force Steering Committee, and Athena San Diego's Bioscience Committee.
PharmAsiaNews.com provides news and analysis on regulatory, legal and financial developments affecting pharmaceutical, biologics and medical device manufacturers doing business in China, India, Japan and the Pacific Rim. Subscribers get original on-the-ground reporting from news bureaus across Asia, guest columns, exclusive interviews, news summaries, English translation summaries of Chinese and Japanese.
